share_log

8-K: Consulting Agreement

8-K: Consulting Agreement

8-K:咨询协议
美股SEC公告 ·  09/17 16:25

Moomoo AI 已提取核心信息

On September 13, 2024, Cassava Sciences, Inc., a biopharmaceutical company, announced the signing of a non-exclusive Consulting Agreement with its former CEO, Remi Barbier. Under the agreement, Barbier will provide consulting services to Cassava for one year, with the option for the company to extend for an additional year. The services will include support for scientific research and assistance in obtaining governmental approvals for the company's products. Barbier will be compensated at a rate of $100 per hour and has agreed to confidentiality and other customary terms. The agreement can be terminated by either party with thirty days' notice and does not affect Barbier's severance benefits as previously reported in a Form 8-K filed on July 17, 2024. The full Consulting Agreement was attached as Exhibit 10.1 to the report.
On September 13, 2024, Cassava Sciences, Inc., a biopharmaceutical company, announced the signing of a non-exclusive Consulting Agreement with its former CEO, Remi Barbier. Under the agreement, Barbier will provide consulting services to Cassava for one year, with the option for the company to extend for an additional year. The services will include support for scientific research and assistance in obtaining governmental approvals for the company's products. Barbier will be compensated at a rate of $100 per hour and has agreed to confidentiality and other customary terms. The agreement can be terminated by either party with thirty days' notice and does not affect Barbier's severance benefits as previously reported in a Form 8-K filed on July 17, 2024. The full Consulting Agreement was attached as Exhibit 10.1 to the report.
2024年9月13日,Cassava Sciences公司,一家生物制药公司,宣布与其前CEO Remi Barbier签订了一份非排他性的咨询协议。根据协议,Barbier将为Cassava提供一年的咨询服务,公司有选择权可以延长一年。这些服务将包括对科学研究的支持,以及协助公司获得政府批准其产品的帮助。Barbier将按每小时100美元的费率获得报酬,并同意保密和其他经常条款。协议可以由任一方在提前通知三十天的情况下终止,并不会影响Barbier之前在2024年7月17日提交的8-k表格中所报告的遣散福利。完整的咨询协议作为附件10.1万亿连接在报告中。
2024年9月13日,Cassava Sciences公司,一家生物制药公司,宣布与其前CEO Remi Barbier签订了一份非排他性的咨询协议。根据协议,Barbier将为Cassava提供一年的咨询服务,公司有选择权可以延长一年。这些服务将包括对科学研究的支持,以及协助公司获得政府批准其产品的帮助。Barbier将按每小时100美元的费率获得报酬,并同意保密和其他经常条款。协议可以由任一方在提前通知三十天的情况下终止,并不会影响Barbier之前在2024年7月17日提交的8-k表格中所报告的遣散福利。完整的咨询协议作为附件10.1万亿连接在报告中。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息